[144] Pegasystems Inc SEC Filing

Rhea-AI Filing Summary

Pegasystems Inc. Form 144 shows a proposed sale of 252 shares of common stock, with an aggregate market value of $14,490.00, against 171,080,665 shares outstanding. The approximate sale date is 09/11/2025 on NASDAQ. The securities were acquired on 09/07/2025 by restricted stock vesting under a registered plan, and payment is listed as Not Applicable. The filer also reported three recent sales by the same person in the past three months: 332 shares on 09/08/2025 for $19,132.06, 235 shares on 09/05/2025 for $12,925.00, and 582 shares on 07/28/2025 for $34,966.30. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.

Positive

• Securities were acquired via restricted stock vesting under a registered plan, indicating planned, authorized compensation-related issuance
• Filing includes prior sales in the past three months, providing transparent disclosure of recent insider transactions

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine insider sale notice for a small block of newly vested restricted shares; no new company disclosures.

The filing documents a proposed sale of 252 shares that vested under a registered restricted stock plan on 09/07/2025 and are to be sold on 09/11/2025. The filing lists prior small sales by the same individual during July and September 2025. There are no statements of undisclosed material adverse information and no changes to the issuer's operational or financial disclosures within this form. This is a compliance filing to notify the market of an insider's intended sale under Rule 144.

Corporate Governance Expert

TL;DR: Disclosure reflects standard insider disposition following restricted stock vesting; governance disclosure obligations met.

The filer identifies the acquisition as restricted stock vesting under a registered plan and provides the required sale schedule and broker information. The notice includes the required certification regarding material nonpublic information. The form does not disclose any governance departures, plan amendments, or additional transaction terms beyond standard Rule 144 disclosure.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	252	14490.00	171080665	09/11/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/07/2025	Restricted stock vesting under a registered plan	Issuer			252	09/07/2025	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
EFSTATHIOS A KOUNINIS 225 Wyman Street Waltham MA 02451	Common	09/08/2025	332	19132.06
EFSTATHIOS A KOUNINIS 225 Wyman Street Waltham MA 02451	Common	09/05/2025	235	12925.00
EFSTATHIOS A KOUNINIS 225 Wyman Street Waltham MA 02451	Common	07/28/2025	582	34966.30

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for PEGA report?

The Form 144 reports a proposed sale of 252 shares of common stock with an aggregate market value of $14,490.00 to be sold approximately on 09/11/2025 on NASDAQ.

How were the 252 shares acquired according to the filing?

The filing states the shares were acquired on 09/07/2025 through restricted stock vesting under a registered plan.

Were there other recent sales by the same person reported in the Form 144?

Yes. The filer reported sales of 332 shares on 09/08/2025 for $19,132.06, 235 shares on 09/05/2025 for $12,925.00, and 582 shares on 07/28/2025 for $34,966.30.

On which exchange is the proposed sale scheduled?

The proposed sale is scheduled on NASDAQ.

Does the filer state any undisclosed material adverse information?

The notice contains the signer’s representation that they do not know of any material adverse information regarding the issuer that has not been publicly disclosed.